DASH Diet + Patient Education for Asthma

(ALOHA Trial)

Not currently recruiting at 1 trial location
AB
JM
Overseen ByJun Ma, MD, PhD
Age: 18+
Sex: Any
Trial Phase: Phase 2 & 3
Sponsor: University of Illinois at Chicago
Must be taking: Controller therapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether the DASH diet (Dietary Approaches to Stop Hypertension) can improve the quality of life for adults with uncontrolled asthma. It compares two asthma care programs: one focuses on patient education, while the other combines education with nutrition counseling from a dietitian. This research could determine if dietary changes can ease asthma symptoms without medication. Individuals with asthma for over two years who struggle to control their symptoms might be suitable candidates. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it does require you to stop using any prescription or non-prescription weight-loss products for the duration of the study.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that the DASH diet is generally safe and easy to follow. Studies have found that this diet can help improve asthma symptoms, especially in children and teens. The DASH eating plan is also known for lowering blood pressure, aiding in weight loss, and reducing the risk of heart disease and Type 2 diabetes. These benefits suggest that the diet is both effective and safe for most people.

The DASH diet emphasizes healthy eating habits, including fruits, vegetables, whole grains, and lean proteins. Since this diet is already recommended for managing high blood pressure, it is considered a safe option for many people, including those considering joining the trial. Studies have not reported any major side effects from the DASH diet, making it a promising and safe choice for those with uncontrolled asthma who want to improve their quality of life.12345

Why are researchers excited about this trial?

Researchers are excited about using the DASH dietary pattern for asthma because it offers a fresh approach compared to the usual medication-based treatments like inhalers and corticosteroids. Unlike these standard treatments that focus on managing symptoms, the DASH diet emphasizes overall health improvement through nutrition, which might reduce inflammation and improve lung function. By combining this diet with patient education and nutrition counseling, there's potential not only for better asthma control but also for enhanced general well-being, making it a holistic alternative to traditional asthma care.

What evidence suggests that the DASH diet might be an effective treatment for uncontrolled asthma?

Research has shown that the DASH diet, known for aiding high blood pressure, might also improve asthma symptoms. One study found that children and teenagers had better asthma control when following the DASH diet. Another small study suggested that adults might also experience improvements in managing asthma with this diet. The DASH diet is associated with better heart health and weight loss, which can indirectly help manage asthma. In this trial, participants in Group B will receive nutrition counseling on the DASH diet, indicating it could be a practical and safe way to assist those with uncontrolled asthma.12467

Who Is on the Research Team?

Ma, Jun | Department of Medicine ...

Jun Ma, MD

Principal Investigator

University of Illinois at Chicago

Are You a Good Fit for This Trial?

Adults over 18 with uncontrolled asthma, as indicated by an Asthma Control Test score below 20, and on prescribed controller therapy can join. They must understand English well enough for informed consent. Exclusions include recent cancer treatment, COPD diagnosis, diabetes outside pregnancy, significant weight change or dieting attempts recently, certain cardiovascular diseases, smoking history or current use, cognitive impairments or severe mental health issues within the last two years.

Inclusion Criteria

I have asthma and am on a prescribed treatment plan.
My asthma is not well-controlled, with an ACT score below 20.
Being able and willing to provide written informed consent and HIPAA authorization

Exclusion Criteria

I have smoked more than 20 packs of cigarettes in my lifetime or am currently smoking.
Planning to move out of the area during the study period
I have diabetes not related to pregnancy.
See 20 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive one of two asthma care programs, including patient education and potentially nutrition counseling, over a 1-year period

52 weeks
3 individual sessions, 8 group sessions, 11 phone consultations

Follow-up

Participants are monitored for safety and effectiveness after treatment

12 weeks
4 visits (in-person) at baseline, 3 months, 6 months, and 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • DASH Dietary Pattern
Trial Overview The ALOHA trial is testing if a DASH dietary intervention improves quality of life in adults with uncontrolled asthma compared to standard patient education. The DASH diet is known to help with high blood pressure but its effects on asthma are unknown. Group B receives nutrition counseling plus education; Group A gets only education.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Group B - Patient Education with Nutrition CounselingActive Control1 Intervention
Group II: Group A - Patinet EducationActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

University of Newcastle, Australia

Collaborator

Trials
12
Recruited
6,100+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

University of Vermont

Collaborator

Trials
283
Recruited
3,747,000+

University of Chicago

Collaborator

Trials
1,086
Recruited
844,000+

Stanford University

Collaborator

Trials
2,527
Recruited
17,430,000+

Published Research Related to This Trial

A 6-month DASH dietary intervention improved diet quality and asthma control in 90 adults with uncontrolled asthma, showing a significant difference in Asthma Control Questionnaire scores compared to the usual-care control group.
While the improvements in asthma control and quality of life were modest, they suggest potential clinical significance, indicating that dietary changes could be beneficial for asthma management.
Pilot randomised trial of a healthy eating behavioural intervention in uncontrolled asthma.Ma, J., Strub, P., Lv, N., et al.[2018]
In a study of 144 overweight or obese adults with high blood pressure, those following the DASH diet alone or with weight management experienced significant reductions in blood pressure compared to those on a usual diet, highlighting the diet's efficacy as a nonpharmacologic treatment.
Greater adherence to the DASH diet was linked to larger decreases in blood pressure, and the study found that African Americans had lower adherence rates, suggesting the need for culturally tailored dietary strategies to improve compliance.
Determinants and consequences of adherence to the dietary approaches to stop hypertension diet in African-American and white adults with high blood pressure: results from the ENCORE trial.Epstein, DE., Sherwood, A., Smith, PJ., et al.[2022]
A 2-month intervention led by a nurse practitioner for 45 overweight and obese hypertensive patients resulted in significant improvements in diet and lifestyle, as measured by standardized questionnaires.
Participants experienced an average weight loss of 3.6 pounds, indicating that the DASH diet and lifestyle changes were effective in promoting better health outcomes in this high-risk group.
Supporting cardiovascular risk reduction in overweight and obese hypertensive patients through DASH diet and lifestyle education by primary care nurse practitioners.Jarl, J., Tolentino, JC., James, K., et al.[2021]

Citations

Association between DASH diet and asthma symptoms ...The findings of the present study showed that following the DASH diet can be associated with the improvement of asthma symptoms in children and adolescents.
DASH for asthma: A pilot study of the DASH diet in not-well ...The “DASH for Asthma” pilot study aims to provide effect size confidence intervals for the change in asthma control. It will also deliver clinical trial and ...
The Science Behind the DASH Eating Plan | NHLBI, NIHThe DASH diet lowers blood pressure, improves the lipid panel, helps people lose weight, and reduces the risk of Type 2 diabetes and heart disease.
The effects of the DASH dietary pattern on clinical ...The effects of the DASH dietary pattern on clinical outcomes and quality of life in adults with uncontrolled asthma: Design and methods of the ALOHA Trial.
Pilot randomised trial of a healthy eating behavioural ...We randomised 90 adults with objectively confirmed uncontrolled asthma and a low-quality diet (Dietary Approaches to Stop Hypertension (DASH) scores <6 out of 9) ...
The DASH Diet for Adults With Uncontrolled AsthmaThis pilot study aims to provide effect size estimates and justification, clinical trial and intervention feasibility data, and procedural materials for a full ...
A pilot study of the DASH diet in not-well-controlled adult ...This pilot study aims to provide effect size confidence intervals, clinical trial and intervention feasibility data, and procedural materials for a ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security